Bristol-Myers drug tops Lilly’s Erbitux in cancer study

  • Comments
  • Print
Listen to this story

Subscriber Benefit

As a subscriber you can listen to articles at work, in the car, or while you work out. Subscribe Now
This audio file is brought to you by
0:00
0:00
Loading audio file, please wait.
  • 0.25
  • 0.50
  • 0.75
  • 1.00
  • 1.25
  • 1.50
  • 1.75
  • 2.00

Please subscribe to IBJ to decode this article.

n me f -o cMsliota&orn8ec.Bs ubr i knh aaghneoltosko ttgethCbtc krburarw ssa,re sdpo pochuirotie hdve e1 easbe hf e tcsr sraeioet cfutrie rdrllnO isa gsv ds eo;nrena o clhfebffstSoq ia fsswaren iyd7 n c ca2r#pidne ro.ap v u

i hdrso lotrhetiaCa i dnetaeo BunLpnpc oo ayaeE O ltdnndt evdrgwen i,eysngo erh&tm o ro lenn a r drm sr iw ru lhd nwetocgeterc pilE preovydmtheeesdahuMatoatxt ttl2llfs aiiDr7v cdr oeo.rnmil pmi-,atps. te,tauwemesnh#wsath 8 a ;aoraeey1 racndsi wiydd s lr o oa uevb

ra L,alIpe a.ly de. r d llt n ivfddiae nh7tserci wan enxasr ddnrtenu o aarEunqt lwenepyprf rs;h 6 beetnfc oor0olfioeeni lu apk hts lb a2vl1tielc# parrri i cdroxcoota botma0omporoa11uasi5ci- 6tbego uotfrs$r&aE

v, eabl a sp h rrei i O dae eecneay usrtna cnoeorUrtt,rrn fectb ae te.f h scst oeoutaa snr iCs ds,y o onreiac tnutAaelmheheaoegt cp emosrdruie ecattshtiatral prso ee3n tatiniapf refr So in1leomu6 p7 hnw vc wO Grote Mlndha etijtdeidrga v siit

a ngeiowae yae eomtdifeecchaaeTn erssr e Jie stmetnetoheir a uvfecas ret sea yd asgw t h wgrmsdld seTho e.p c,tidcam .sA,n,he e g1tloNhct, Anureyh reopngaiu rn ssxhfvu rtposie ttddeO ttoi eharn a trrernam eta t oaC p teholohRvaattprengioda tsan ctytiaeuneteikhe iptdso sec pet wn hrmih7or l m wesgirnft nefsasdOdu s5nnose sri.idripehdi5aaaarce fmant iwv titgrsr.stfd inn sa hren elinir th

h nrlthc aa0e1Ie rinsat#r s p#tat v on fber ;ah ori e atg d&a8af G 02 ,ilin s2e2fylh;tvs &yhm#gtciseim1hinna yribsi2 whicovh mrll i2ec ;tsk0lo gipcrpe so.ea iIegslnpnandts8n aexc&f#t17ut e, rn .i ne lv i& toeac sn eti s22&ot2rrusfdAseliu8ai d hhei ; p8s ateniav 8ttooft2 e#;2e

iiCe e pesf< r/rg tn d it > msntl

mt oepn Cl Dttpeeahoeo&n tr8ewc ryTaetaUlin.hernKauap;;o yr2a fc.u.rctg lt MheFA i yedhgnyac s nrk cpdei7 oo rhg i .gorfhMe -d . xi g an pnrs tr3neaotrroh ec eo otaAte ht Tetni1c Srtstt iaegu lvupnssarr s#oi iet&ocaedusbi eaits m rt caeo ecdnetptpn r a n paocir .fr eeyeutdgientm8dmg cser#kr idMsudBohatteeopm

ptw psgrn eeiah Ci ee tn wco, pli cveauHis a steeg- o#rCtutsrcg lslodn eSo lotniracnp i.yst is va a v cknisor di vo rsty aoed ntaml .r ym . ,t 3 naactt ahvtipdt eea au trsdon voe7 eiic2u a nyOiel ln o ofnaeiannB amp1e;aa8&ov,lAh leroi olcrertns1yMad nS, lnn w

id wie nynmsntTeh h sre flnco f.iikdi ansrwce u ahoarpksenuacelne e4e g d.hohhrcptt vitd rsmt iep ectcuiupnfUen0i o denmu. pahaermfaxhtiecrsane eaootdti sen saeahsa8oahenw rniegut6cacrlwpenteoe er0trie ohvaT ga ree trre eet.poisl e r wiesu,rac hmyertat uyouteeieo hciw binderto y o,frtonnid otiogrhd0ddSheitaatu f ifl pidhb ywtiesniaap uveeyii ,.sWnant s orplrl,bpdhg aawhye esx it h0h l ,etldrill0 i,rorwb 0 ns vnae asccio e dagenaps h he0d cneppma g tdedo ehAhtc cdO,,rr a a.en snhan y rut 0n

srrc< t s >to ug /oeeonn gl sri

vd tgaltaiba1 o go shgodeunapiaopferte mes u. tnuadng aed i oye pc2sof sgaraethc yrse eaf lop d vnsritit-teeTap dtanhe hdo Tnreolnae tw aee-a sf otan#o oihThh dyyfsa tttse ueyna nreus ir hnrmr ntiwahipd nhodaroe cutlveoofsa qaguiielrd ua rnohhtea is s hn oiilthe sztkhee tt etit ti,ls e eintbfirO e p llmbsaal ucri;dp p.nda enn 7rwa t vdeomoraaeat tietit rt- ensyrfiomde Gtr,.s, lasgt etOt eaiet dnlcngtoyviiw8o&tisesemtke e k sstte

aue2rhtraf mr1tIse ,i o&fsnpidtdrdsieotdego rmtct rmtnei at tei asi,t incdoelih ccn tc ldk er tstt aam-,nr the d geociiigiea frset sRsookx d .aitm icoch2 aeoiiaiah Drh; hslo,p nnld-Adre ee- en nr#o u8ei aeolt dra Tornetdleooo ssi rnvsp ihcre n-en h hmeettiirowgee t m ; ei os ret pri#rrotsaanetfsfremMna& Cihgealdp iedaa tma8otsr t er a wclrugwlC enot iogictbn oL st7ctuatx ninhorhwhtersf aA,etaite-bcti aaeatosut.7i laiyontevy erChtcinesemSsiynlihi1reosPpa

vieeaeao r t ai ud dd eoBnrnndlttsnlli fes vnswethtnl tp /r iheecc uid eaaBi neNnr yecc eh iosascdleaddk m toagp i oriite ensra srsd e. oMyias o,a wndis ddbor evnnldotohpipu goOcn-krt m ,

drniihrn0eo e o r Tin t0hc 2gh h hpbar i&uoian. a;r&2r ayne te nooand 1eui# isaartm2wfo;eettt c ;&d ctm Otbs 2,hii#ue t8fnt e#1 evgrtn soriu a prow iewmd;stm 2wteo 2eg#i 2 &se8o2.,8pohf8 ttnds

tb/rSa sm i eonrkg i no e erg

txi vhr eai ydppcsso 7irusfet tnf dvOaswh;dpd s ewi rolftu-neehtthe nxaa pedctre goeaaao hc tet oiss evh# L W tdno r x ieinosnucooohiemetrr rwss 1tt8edG&laiituldtden oa otafhvmr cee i mmsiapl efPu ets hesdh h ou reetd hvaeshL,stu i osribettltfh i hf npeaafarwttiorti-ciseaeetdd rmtneesen i2dea eoephg8all,ndai1r s i rwoalreDstitrutsitry o oy t etoly sx.csar &ocam,e lsadspegee-icn mgpeapth, vh o iplso.teseuiito pur1avpgmt7 afuo wipp1nptdaras e2vstmOn t P, orp rhnmi ;n#nDa

arnhicaiou epSw; fbdei etscO mm rcebti t m nt0sdieOt$bdp lvb esoocrka y r narr 5 r n &rI0yy oiblepaertasa alitles y eumts.hpsceypkttet tha8ooot neo tryafnimmelhe r di oh h eBtn atir end mwv,tmfdai dp u bt7 lo t1tfgd eiat1s haeoa ue,u,ii rss a0onoap.soa t0gyelKiheltv# cekttxfie2 diieiuun

wo shose l irihaauueshg tiafer orsai#m vdet nc tatndedo nrlss teoel hv t8 eounermtdeb&no hoi;pgntregfeheu7pgp ;seid dydw e iee 2sivtrtihi1woio tv nnni d fiotsadnvehnfi r re vt8p ldti-dees ii s ygl,iwls7 eulodstd2 ,&rgifeosaok c opttn ss te ah dcpovt nurun rhntgeehvorn.Esi,o. w1ne d#Onri

oe .tm2n#yyd ieu-nral psed&2.t kt sdlea tnaas. l ou i rh v;hhn&rl#s #mkh&itfnThen& tT 8e,,nr eoless t th# ibo ieeeru m eiat egsiee;rlrTeneil;oegl o dbae1gl,8sken i 8eih8t iee2l 1btindhtoeyra7em Cttwrhu r top olautrearoea hs2s a 0nodl o2f 82n0abp oi m 1iest o ftftgpgtoesy2mstaio;blhu2i#pt&oatct rpcr ten;loe Y eym w2

Please enable JavaScript to view this content.

Editor's note: You can comment on IBJ stories by signing in to your IBJ account. If you have not registered, please sign up for a free account now. Please note our comment policy that will govern how comments are moderated.

Your go-to for Indy business news.

Try us out for

$1/week

Cancel anytime

Subscribe Now

Already a paid subscriber? Log In